We sought to define how the early cognitive deficits in newly diagnosed patients with Parkinson’s disease map onto changes in brain activation, and how these activations in patients varied as a function of the common genetic variations in COMT, MAPT and APOE. This evidence concerns the gene MAPT and Parkinson disease.